0001062993-23-001326.txt : 20230124 0001062993-23-001326.hdr.sgml : 20230124 20230124160849 ACCESSION NUMBER: 0001062993-23-001326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230120 FILED AS OF DATE: 20230124 DATE AS OF CHANGE: 20230124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snow Ellen CENTRAL INDEX KEY: 0001786643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39969 FILM NUMBER: 23548228 MAIL ADDRESS: STREET 1: C/O PEAR THERAPEUTICS, INC. STREET 2: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001835567 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 854103092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Thimble Point Acquisition Corp. DATE OF NAME CHANGE: 20201208 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-01-20 0001835567 Pear Therapeutics, Inc. PEAR 0001786643 Snow Ellen C/O PEAR THERAPEUTICS, INC. 200 STATE STREET, 13TH FLOOR BOSTON MA 02109 0 1 0 0 Chief Accounting Officer Class A Common Stock 2023-01-20 4 S 0 8027 1.13 D 23318 D The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. /s/ Stacie S. Aarestad, Attorney-in-Fact 2023-01-24